Rocepafant

• Description:

  Rocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.Rocepafant inhibits tumor necrosis factor-Afa-mediated cytotoxicity in mouse L929 tumor cells.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  535.08

• Molecular Formula:

  C26H23ClN6OS2

• Notes:

  Research use only, not for human use.

• Receptor:

  Platelet aggregation

• CAS Number:

  132579-32-9